参考文献/References:
1 Kaschtem B, Stevenaert A, Sadzok B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or C-11 MET[J]. J Nucl Med, 1998, 39(5):778-785.
2 Ribom D, Engler H, Blomquist E, et al. Potential signiticance of 11C-methionine PET as a maeker for the radiosensitivity of low-grade gliomas[J]. Eur J Nucl Med, 2002, 29(5):632-640.
3 Pirotte B, Goldman S, Dacid P, et al. Stereotactic brain biopsy guided by positron emission tomography(PET) with F-18-fluorodeoxyglucose and C-11 methionine[J]. Acta Neurochir Suppl, 1997, 68:133-138.
4 Tsuyuguchi N, Takam T, Sunada T, et al. Methionine Positron Emission Tomography for differentiation of recurrent brain tumor and radiation necrosis after sterotactic radiosurgery in malignant glioma[J]. Ann Nucl Med, 2004,18(4):291-296.
5 Tashima T, Moriokat T, Nishio S, et al. Delayed cerebral radionecrosis with high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single photo emission computer tomography[J]. Neuroradiogy, 1998, 40(7):435-438.
6 Nakagawa M, Kuwabara Y, Sasaki M, et al. 11C-methionine uptake in cerebrovascular disease:a comparison with 18F-FDG PET and 99mTc-HMPAO SPECT[J]. Ann Nucl Med, 2002,16(3):207-211.
7 Nobusada S, Masshiro N, Tetsuo H, et,al. Brain tumors:detection with C-11 choline PET[J]. Radiology, 1997, 202(2):497-503.
8 Pieterman RM, Que TH, Eisinga PH, et al. Comparison of 11C-choline and 18F-FDG PET in primary diagnosis and staging of patients with thoracic cancer[J]. J Nucl Med, 2002, 43(2):167-172.
9 Liu RS. Clinical application of [C-11] acetate in oncology[J]. Clin Positron Imaging, 2000, 3(4):185.
10 Kallio SL, Nagern N, Lehikoinen P, et al. Carbon-11 methionine and PET is an efficientive method to image head and neck cancer[J]. J Nucl Med, 1992, 33(5):691-695.
11 Khan N, Oriuchi N, Ninomiya H, et al. Positron emission tomographic imaging with 11C-choline in differentical diagnosis of head and neck tumors:Comparison with 18F-FDG[J]. Ann Nucl Med, 2004,18(5):409-417.
12 Ninomiya H, Oriuchi N, Khan N, et al. Diagnosis of tumor in the nasal cavity and paranasal sinuses with 11C-choline PET:Comparative study with FDG PET[J]. Ann Nucl Med, 2004, 18(1):29-34.
13 Yasukawa T, Yoshikawa K, Aoyagi H, et al. Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer[J]. J Nucl Med, 2000, 41(2):283-290.
14 Ishimori T, Saga T, Nagata Y, et al. 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy[J]. Ann Nucl Med, 2004, 18(8):669-674.
15 Khan N, Oriuchi N, Zhang H, et al. A comparative study of 11C-choline PET and 18F-fluorodeoxyglucose PET in the evaluation of lung cancer[J]. Nucl Med Commun, 2003, 24(4):359-366.
16 Higashi K, Ueda Y, Matsunari I, et al. 11C-acetate PET imaging of lung cancer:comparison with 18F-FDG PET and 99mTc-MIBI SPET[J]. Eur J Nucl Med Mol Imaging, 2004, 31(1):13-21.
17 Iwata Y, Shiomi S, Asaski N, et al. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors[J]. Ann Nucl Med, 2000, 14(2):121-126.
18 Ho CL, Yu SCH, Yeung D. 11C-Acetate PET imaging in hepatocellular carcinoma and other liver masses[J]. J Nucl Med, 2003, 44(2):213-221.
19 Lapela M, Kallio SL, Varpula M, et al. Metablic imaging of ovarian tumors with carbon-11 methionine:a PET study[J]. J Nucl Med,1995, 36(12):2196-2200.
20 Torizuka T, Kanno T, Futatsubashi M, et al. Imaging of gynecologic tumors:Comparison of 11C-choline PET with 18F-FDG PET[J]. JNucl Med, 2003, 44(7):1051-1056.
21 Hofer C, Laubenbacher C, Block T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy[J]. Eur Urol, 1999, 36(1):31-35.
22 Kato T, Tsukamoto E, Kuge Y, et al. Accumulation of [11C] acetate in normal prostate and benign prostatic hyperplasia:comparison with prostate cancer[J]. Eur J Nucl Med, 2002, 29(11):1492-1495.
23 Sutinen E, Nurmi M, Roivainen A, et al. Kinetics of 11C-choline uptake in prostate cancer:A PET study[J]. Eur J Nucl Med Mol Imaging, 2004, 31(3):317-324.
24 Toth G, Lengyel Z, Balkay L, et al. Detection of prostate cancer with 11C-methionine positron emission tomography[J]. J Urol, 2005,173(1):66-69.
25 Jong IJ, Pruim J, Elsinga PH, et al. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET[J]. J Nucl Med,2003, 44(3):331-335.
26 Nanez R, Macapinlac HA, Yeung H, et al. Combained 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer[J]. J Nucl Med, 2002, 43(1):46-55.
27 Picchio M, Messa C, Landoni C, et al. Value of 11C-choline positron emission tomography for re-staging prostate cancer:a comparison with 18F-fluorodeoxyglucose positron emission tomography[J]. J Urol,2003, 169(4):1337-1340.
28 Kotserke J, Volkmer BG, Neumaier B, et al. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer[J]. Eur J Nucl Med, 2002, 29(10):1380-1384.
29 Schöder H, Larson SM. Positron emission tomography for prostate,bladder and renal cancer[J]. Semin Nucl Med, 2004, 34(4):274-292.
30 Jong I J, Pruim J, Elsinga P, et al. Visualisation of bladder cancer using 11C-choline PET:first clinical experience[J]. Eur J Nucl Med,2002, 29(10):1283-1288.
31 Zhang H, Tian M,Oriuchi N, et al. 11C-choline PET for detection of bone and soft tissue tumors in comparison with 18F-FDG PET[J].Nucl Med Commun, 2003, 24(4):273-279.
32 Yanagawa T, Watannabe H, Inoue T, et al. Carbon-11 choline positronemission tomography in musculoskeletal tumors:Comparsion with fluorine fluorodeoxyglucose positron emission tomography[J]. J Comput Assist Tomogr, 2003, 27(2):175-182.
33 Kobori O, Kirihara Y, Kosaka N, et al. Positron emission tomography of esophageal carcinoma using 11C-choline and 18F-fluorodeoxyglucose[J]. Cancer, 1999, 86(9):1638-1648.
34 Shreve P, Chiao PC, Humes D, et al. Carbon-11 acetate imaging in renal disease[J]. J Nucl Med, 1995, 36(9):1595-1601.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]